What is the current Hematology Device market size?

Global Hematology Device market size surpassed USD 5.4 billion in 2023, propelled by rising blood disorder diagnostics and hospital automation.

What is the forecast growth rate through 2030?

Analysts project a 6.1% CAGR, elevating the market to USD 8.2 billion by 2030, underpinned by chronic disease screening and tech upgrades.

Which factors are driving demand?

Key drivers include aging populations, leukemia prevalence, 5-part diff analyzer uptake, and reimbursement for point-of-care hematology testing.

What challenges restrain growth?

High instrument cost, service contracts, stringent FDA and IVDR validation, and hospital capital budget limits create adoption barriers worldwide.

Which region leads the market?

North America holds 38% share, driven by CMS coverage, CLIA labs, and major OEM presence; Asia-Pacific is fastest growing at 8% CAGR.

Who are the top companies?

Sysmex, Beckman Coulter, Abbott, Siemens Healthineers, Boule, and Horiba dominate through broad menus, automation, and global service.

What future outlook presents opportunities?

The future outlook highlights AI-enhanced morphology, microfluidic cartridges for rural markets, and bundled rental models unlocking price-sensitive regions.

How is technology reshaping hematology?

Digital cell imaging, cloud-based QC analytics, and AI pattern recognition shorten TAT, reduce slide reviews, and personalize therapy decisions.

What is the regulatory landscape?

FDA 510(k) clearances focus on CLIA waivers; EU IVDR demands post-market surveillance, affecting launch timelines for new hematology parameters.

Hematology Device Industry Trends & Competitive Analysis 2033

Hematology Device by Application (Hospital/Clinics, Independent Diagnostic, Laboratories), by Types (Analyzers, Coagulation Instrument, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Hematology Device Market Size | CAGR 2019 Forecast 2033

Hematology Device Industry Trends & Competitive Analysis 2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Hematology Device Market Overview

via questions

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	HORIBA; Abbott Laboratories; Siemens Healthineers; Bio-Rad Laboratories; Danaher Corporation; BD (Becton, Dickinson and Company); Roche Diagnostics; Sekisui Diagnostics; Axis-Shield Diagnostics; Chrono-Log Corporation; Sysmex Corporation; Stratec SE (Diatron); Boule Diagnostics; Nihon Kohden Corporation; Mindray Medical International; DyMind; Urit Medical Electronics; Rayto Diagnostics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

by adding

Regional Insights

Loading chart…

North America remains the largest contributor to Hematology Device market growth, commanding a 38% share, driven by CMS reimbursement alignment, consolidated health networks accelerating 5-point-of-care rollouts, and a rising 65+ demographic demanding >120 million blood counts annually. Regional forecast indicates mid-single-digit CAGR through 2028.

Europe (28%) leverages IVDR-driven quality premiums, harmonised hospital procurement, and a €1.4 billion EU cancer plan to sustain replacement demand, while Asia Pacific emerges as the fastest-growing region (22%) on the back of 1.1 billion screening initiatives, price-elastic 3-part analyzers, and $2.3 billion private infrastructure investments.

Key regional drivers5 items

North America: reimbursement, consolidation, ageing

Europe: IVDR, EU cancer plan, procurement

Asia Pacific: screening, price elasticity, FDI

Latin America (8%) expands via PAHO bulk tenders, SUS lab build-outs, and 200% telehematology growth

Middle East & Africa (4%) prioritises PPP haematology hubs, compulsory premarital screening, and WHO Essential Diagnostics List adoption

Competitive Landscape

via market

Key Hematology Device Companies18 items

HORIBA

Abbott Laboratories

Siemens Healthineers

Bio-Rad Laboratories

Danaher Corporation

BD (Becton, Dickinson and Company)

Roche Diagnostics

Sekisui Diagnostics

Axis-Shield Diagnostics

Chrono-Log Corporation

Sysmex Corporation

Stratec SE (Diatron)

Boule Diagnostics

Nihon Kohden Corporation

Mindray Medical International

DyMind

Urit Medical Electronics

Rayto Diagnostics

Market Ecosystem

The Hematology Device ecosystem spans upstream component fabrication, mid-stream system assembly, and downstream clinical deployment, with value created through miniaturised optics, microfluidics, and reagent chemistry that are integrated into analysers, validated by regulators, and sold via capital-equipment channels to hospital, reference-lab, and research end users.

Optical & fluidic component suppliers — deliver lasers, detectors, syringe pumps to OEMs under ISO 13485 traceability

Reagent & consumable vendors — formulate sheath fluids, diluents, lyse that lock chemistries to specific analyser ports

Device OEMs — design hardware, software, algorithms; secure 510(k)/CE marks; set list pricing and service packages

Authorised distributors — hold inventory, lease floor models, perform installations, coordinate training for mid-sized labs

After-sales service providers — maintain calibration, QC, and service contracts; manage uptime SLAs and parts logistics

Regulators & proficiency-test bodies — enforce CLIA, IVDR, CAP checklists; influence reimbursement and adoption speed

End-user laboratories — control purchase budgets, validate reference ranges, generate sample throughput driving reagent pull-through

OEMs capture margin by bundling proprietary reagents with closed-system hardware; switching costs centre on locked calibrators, QC materials, and LIS interfaces that require revalidation. Distribution partners act as gatekeepers for capital budgets, while regulators can halt launches through analyte-specific scrutiny. Supply chain risk concentrates on optical components and fluorochrome shortages; multi-year service contracts and ISO 15189 compliance create sticky revenue, but regional tender rules in APAC and LATAM compress pricing tiers.

Recent Industry Insights

type using be adding,.:

by the

Analyst Overview

The Hematology Device market outlook signals a highly attractive growth environment, underpinned by aging populations, rising blood disorders, and expanding point-of-care needs. Competitive intensity is moderate but rising: global incumbents dominate installed bases, yet nimble niche players are rapidly differentiating on AI-driven cell classification and microfluidic platforms, compressing pricing power. Over the next decade, we forecast a 5–6 % CAGR with margin resilience for firms that vertically integrate reagents and software, while pure-play hardware vendors risk commoditization.

Innovation is pivoting from incremental throughput gains to predictive analytics and closed-loop hemoglobin monitoring, opening new revenue pools beyond capital sales. Supply chains for optical components and semiconductor chips remain adequate, though geopolitical export restrictions on rare-earth magnets pose a latent chokepoint. Key risks include reimbursement compression in OECD markets, potential delays in FDA 510(k) clearances for AI algorithms, and currency volatility in emerging economies that account for ~35 % of forecast demand.

11 items

1. Executive Summary

2. Hematology Device Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Hematology Device Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Hematology Device Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital/Clinics

6.1.2. Independent Diagnostic

6.1.3. Laboratories

6.2. Global Hematology Device Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Analyzers

6.2.2. Coagulation Instrument

6.2.3. Other

6.3. Global Hematology Device Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Hematology Device Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Hematology Device Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Hematology Device Market Competition by Key Manufacturers

8.1. Global Hematology Device Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Hematology Device: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. HORIBA

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Abbott Laboratories

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Siemens Healthineers

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Bio-Rad Laboratories

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Danaher Corporation

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. BD (Becton, Dickinson and Company)

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Roche Diagnostics

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Sekisui Diagnostics

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Axis-Shield Diagnostics

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Chrono-Log Corporation

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Sysmex Corporation

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Stratec SE (Diatron)

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Boule Diagnostics

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Nihon Kohden Corporation

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Mindray Medical International

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. DyMind

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Urit Medical Electronics

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Rayto Diagnostics

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Hematology Device Market

Figure 4: Global Hematology Device Market: Drivers

Figure 5: Global Hematology Device Market: Challenges

Figure 6: Global Hematology Device Market: Trends

Figure 7: Global Hematology Device Market: Opportunity

Figure 8: Global Hematology Device Market: Restraint

Figure 9: Global Hematology Device Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Hematology Device Market Value (USD Million) By Region

Figure 15: Global Hematology Device Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Hematology Device Market Value (USD Million) By Region

Figure 23: Global Hematology Device Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

89 items

Table 1: Market Segmentation Analysis

Table 2: Global Hematology Device Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Hematology Device Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Hematology Device Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Hematology Device Market Value (USD Million) By Region

Table 10: Global Hematology Device Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Hematology Device Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Hematology Device Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Hematology Device Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: HORIBA Basic Information And Sales Area

Table 31: HORIBA. Products Portfolio

Table 32: Abbott Laboratories Basic Information And Sales Area

Table 33: Abbott Laboratories. Products Portfolio

Table 34: Siemens Healthineers Basic Information And Sales Area

Table 35: Siemens Healthineers. Products Portfolio

Table 36: Bio-Rad Laboratories Basic Information And Sales Area

Table 37: Bio-Rad Laboratories. Products Portfolio

Table 38: Danaher Corporation Basic Information And Sales Area

Table 39: Danaher Corporation. Products Portfolio

Table 40: BD (Becton, Dickinson and Company) Basic Information And Sales Area

Table 41: BD (Becton, Dickinson and Company). Products Portfolio

Table 42: Roche Diagnostics Basic Information And Sales Area

Table 43: Roche Diagnostics. Products Portfolio

Table 44: Sekisui Diagnostics Basic Information And Sales Area

Table 45: Sekisui Diagnostics. Products Portfolio

Table 46: Axis-Shield Diagnostics Basic Information And Sales Area

Table 47: Axis-Shield Diagnostics. Products Portfolio

Table 48: Chrono-Log Corporation Basic Information And Sales Area

Table 49: Chrono-Log Corporation. Products Portfolio

Table 50: Sysmex Corporation Basic Information And Sales Area

Table 51: Sysmex Corporation. Products Portfolio

Table 52: Stratec SE (Diatron) Basic Information And Sales Area

Table 53: Stratec SE (Diatron). Products Portfolio

Table 54: Boule Diagnostics Basic Information And Sales Area

Table 55: Boule Diagnostics. Products Portfolio

Table 56: Nihon Kohden Corporation Basic Information And Sales Area

Table 57: Nihon Kohden Corporation. Products Portfolio

Table 58: Mindray Medical International Basic Information And Sales Area

Table 59: Mindray Medical International. Products Portfolio

Table 60: DyMind Basic Information And Sales Area

Table 61: DyMind. Products Portfolio

Table 62: Urit Medical Electronics Basic Information And Sales Area

Table 63: Urit Medical Electronics. Products Portfolio

Table 64: Rayto Diagnostics Basic Information And Sales Area

Table 65: Rayto Diagnostics. Products Portfolio

Table 66: Global Market Value (USD Million) (2025-2032) By Application

Table 67: Global Market Share (%) By Application (2032)

Table 68: Global Market Value (USD Million) (2025-2032) By Types

Table 69: Global Market Share (%) By Types (2032)

Table 70: Global Hematology Device Market Value (USD Million) By Region

Table 71: Global Hematology Device Market Share (%) By Region (2025-2032)

Table 72: North America Market Value (USD Million) (2025-2032) By Country

Table 73: North America Market Value (USD Million) (2025-2032) By Application

Table 74: North America Market Value (USD Million) (2025-2032) By Types

Table 75: Europe Market Value (USD Million) (2025-2032) By Country

Table 76: Europe Market Value (USD Million) (2025-2032) By Application

Table 77: Europe Market Value (USD Million) (2025-2032) By Types

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 81: South America Market Value (USD Million) (2025-2032) By Country

Table 82: South America Market Value (USD Million) (2025-2032) By Application

Table 83: South America Market Value (USD Million) (2025-2032) By Types

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 87: Research Programs/Design For This Report

Table 88: Key Data Information From Secondary Sources

Table 89: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Hematology Device Market Overview

via questions

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	HORIBA; Abbott Laboratories; Siemens Healthineers; Bio-Rad Laboratories; Danaher Corporation; BD (Becton, Dickinson and Company); Roche Diagnostics; Sekisui Diagnostics; Axis-Shield Diagnostics; Chrono-Log Corporation; Sysmex Corporation; Stratec SE (Diatron); Boule Diagnostics; Nihon Kohden Corporation; Mindray Medical International; DyMind; Urit Medical Electronics; Rayto Diagnostics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options